Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.
Intrinsic and acquired multidrug resistance (MDR) is an important problem in cancer therapy. MDR in human KB carcinoma cells selected for resistance to colchicine, vinblastine, or doxorubicin (former generic name adriamycin) is associated with overexpression of the "MDR1" gene, which encodes P-glycoprotein. We previously have isolated an overlapping set of cDNA clones for the human MDR1 gene from multidrug-resistant KB cells. Here we report the construction of a full-length cDNA for the human MDR1 gene and show that this reconstructed cDNA, when inserted into a retroviral expression vector containing the long terminal repeats of Moloney leukemia virus or Harvey sarcoma virus, functions in mouse NIH 3T3 and human KB cells to confer the complete multidrug-resistance phenotype. These results suggest that the human MDR1 gene may be used as a positive selectable marker to introduce genes into human cells and to transform human cells to multidrug resistance without introducing nonhuman antigens.
Ueda
K
K
Cardarelli
C
C
Gottesman
M M
MM
Pastan
I
I
D003078:Colchicine / Q000494:pharmacology*; D004247:DNA / Q000378:metabolism*; D004317:Doxorubicin / Q000494:pharmacology*; D004351:Drug Resistance; D005796:Genes; D006801:Humans; D007624:KB Cells; D009693:Nucleic Acid Hybridization; D010957:Plasmids; D014158:Transcription, Genetic; D014747:Vinblastine / Q000494:pharmacology*
D014747:Vinblastine; D004317:Doxorubicin; D004247:DNA; D003078:Colchicine